Strategic CDMO Scale Phillips Medisize operates as a large contract development and manufacturing organization with 30 development and manufacturing sites across three continents and a 6,000+ employee capability, indicating strong capacity to scale partnerships for pharmaceutical, medtech, and IVD clients.

Diverse Customer Base The company serves world-leading pharma, medtech, and in vitro diagnostic companies, signaling opportunities to partner on complex products across multiple modalities, from drug delivery to diagnostic devices.

Innovation Pipeline Recent launches and collaborations such as TheraVolt Medical Connectors and partnerships with companies like Medtronic highlight a focus on advanced connectivity, device integration, and next-generation delivery systems that can be leveraged for new business wins.

Regulatory & Quality Backbone With ISO 9001 and ISO 14644 certifications and a track record of navigating regulatory demands through CDMO collaborations, the company offers a proven quality framework appealing to risk-conscious customers seeking compliant manufacturing and development.

Industry Engagement Active participation in industry events (ADLM, RDD) and demonstrated thought leadership through lectures and presentations create inbound sales opportunities and partner signaling with potential clients seeking collaboration on complex builds.